Synthetic lethality screen identifies novel druggable targets in the MYC pathway

被引：0
|
作者：
Li, Yulin [1 ]
Deutzmann, Anja [1 ]
Bell, John [1 ]
Ji, Hanlee [1 ]
Felsher, Dean [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2017年 / 16卷 / 10期
关键词：
D O I：
10.1158/1538-8514.SYNTHLETH-PR02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PR02
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Splicing and Dicing MYC-Mediated Synthetic Lethality
    Stine, Zachary E.
    Dang, Chi V.
    CANCER CELL, 2015, 28 (04) : 405 - 406
  • [22] MYC-Mediated Synthetic Lethality for Treating Tumors
    Li, Xin
    Zhang, Xin A.
    Li, Xiaoqing
    Xie, Wei
    Huang, Shiang
    CURRENT CANCER DRUG TARGETS, 2015, 15 (02) : 99 - 115
  • [23] siRNA screen identifies QPCT as a druggable target for Huntington's disease
    Jimenez-Sanchez, Maria
    Lam, Wun
    Hannus, Michael
    Soennichsen, Birte
    Imarisio, Sara
    Fleming, Angeleen
    Tarditi, Alessia
    Menzies, Fiona
    Dami, Teresa Ed
    Xu, Catherine
    Gonzalez-Couto, Eduardo
    Lazzeroni, Giulia
    Heitz, Freddy
    Diamanti, Daniela
    Massai, Luisa
    Satagopam, Venkata P.
    Marconi, Guido
    Caramelli, Chiara
    Nencini, Arianna
    Andreini, Matteo
    Sardone, Gian Luca
    Caradonna, Nicola P.
    Porcari, Valentina
    Scali, Carla
    Schneider, Reinhard
    Pollio, Giuseppe
    O'Kane, Cahir J.
    Caricasole, Andrea
    Rubinsztein, David C.
    NATURE CHEMICAL BIOLOGY, 2015, 11 (05) : 347 - U144
  • [24] SiRNA screen identifies QPCT as a druggable target for Huntington's disease
    Jimenez-Sanchez M.
    Lam W.
    Hannus M.
    Sönnichsen B.
    Imarisio S.
    Fleming A.
    Tarditi A.
    Menzies F.
    Ed Dami T.
    Xu C.
    Gonzalez-Couto E.
    Lazzeroni G.
    Heitz F.
    Diamanti D.
    Massai L.
    Satagopam V.P.
    Marconi G.
    Caramelli C.
    Nencini A.
    Andreini M.
    Sardone G.L.
    Caradonna N.P.
    Porcari V.
    Scali C.
    Schneider R.
    Pollio G.
    O'Kane C.J.
    Caricasole A.
    Rubinsztein D.C.
    Nature Chemical Biology, 2015, 11 (5) : 347 - 354
  • [25] Mapping chromatin remodelling in glioblastoma identifies epigenetic regulation of key molecular pathways and novel druggable targets
    Claire Vinel
    James Boot
    Weiwei Jin
    Nicola Pomella
    Alexandra Hadaway
    Charles Mein
    Nicolae Radu Zabet
    Silvia Marino
    BMC Biology, 23 (1)
  • [26] Multiomics analysis of hepatoblastoma identifies novel druggable targets NQO1 and ODC1
    Sekiguchi, Masahiro
    Seki, Masafumi
    Yoshida, Kenichi
    Tanaka, Mio
    Shirai, Ryota
    Souzaki, Ryota
    Shiraishi, Yuichi
    Hiwatari, Mitsuteru
    Kato, Motohiro
    Taguchi, Tomoaki
    Tanaka, Yukichi
    Miyano, Satoru
    Ogawa, Seishi
    Takita, Junko
    CANCER SCIENCE, 2021, 112 : 315 - 315
  • [27] Synthetic lethality: emerging targets and opportunities in melanoma
    Thompson, Nicola
    Adams, David J.
    Ranzani, Marco
    PIGMENT CELL & MELANOMA RESEARCH, 2017, 30 (02) : 183 - 193
  • [28] Phosphatases are emerging as novel druggable targets in Plasmodium
    Khalife, Jamal
    Pierrot, Christine
    FUTURE MICROBIOLOGY, 2016, 11 (05) : 603 - 606
  • [29] Novel Biomarkers and Druggable Targets in Advanced Melanoma
    Ferrucci, Pier Francesco
    Cocorocchio, Emilia
    CANCERS, 2022, 14 (01)
  • [30] Synthetic lethality screen identifies a novel yeast myosin I gene (MYO5): Myosin I proteins are required for polarization of the actin cytoskeleton
    Goodson, HV
    Anderson, BL
    Warrick, HM
    Pon, LA
    Spudich, JA
    JOURNAL OF CELL BIOLOGY, 1996, 133 (06): : 1277 - 1291
12345